The European Association for Cancer Research
Advancing cancer research - from basic research to prevention, treatment and care
About the EACR
The European Association for Cancer Research was established in 1968 and the membership now exceeds 6000 including the following Society Members:
- Arbeitsgemeinschaft experimentelle Krebsforschung (AEK) der Deutschen Krebsgesellschaft
- Asociación Española de Investigación sobre el Cáncer (ASEICA)
- British Association for Cancer Research (BACR)
- Magyar Onkológusok Társasága (MOT) (Hungarian Cancer Society)
- Società Italiana di Cancerologia (SIC)
- Société Française du Cancer, (SFC)
Benefits of membership leaflet
Click here to download the leaflet giving you more information on membership benefits.
The Association offers opportunities for:
Communication
- with laboratory, translational and clinical cancer researchers in all areas of oncology - from basic research, to prevention, treatment and care
- at meetings and special conferences
- with partner international cancer organizations
- in our scientific journal (European Journal of Cancer)
- through the EACR Newsletters
Advance information
- on significant events and initiatives in the European and International fields of oncology
Contacts and opportunities for collaborative research
- with and within other Member Societies of the European CanCer Organisation (ECCO), of which EACR is a founder member
Education and Training for the Young Cancer Researcher
- Free membership for postgraduate students
- Fellowships to promote technical exchange and the acquisition of expertise
- Awards for lectures and posters at meetings
- Bursaries to attend main EACR meetings
- Special programmes to assist researchers in Eastern Europe
Reduced registration rates
- Reduced registration rates at EACR biennial meetings and ECCO meetings
Reduced subscription
- Reduced subscription rates for the European Journal of Cancer (EJC)
Membership
Membership is open to those who possess an academic degree or the equivalent and have an appointment or work actively in cancer research.
Free student membership is available for post-graduate students
Further details and application form.
Governance
The General Assembly, as the supreme governing body of the Association, is composed of the membership of the EACR. The Executive Committee conducts the affairs of the Association and is advised by the Council.
EACR gratefully acknowledges the support of its Sustaining Members
- Affymetrix
- Agilent Technologies
- Applied Biosystems
- Bayer Schering Pharma AG
- Illumina
- Novartis
- Susan G Komen for the Cure
And its Sponsors:
- Association for International Cancer Research AICR
- Biotage
- Carcinogenesis
- Pezcoller Foundation
Other useful links
European CanCer Organisation (ECCO)
Members' Log in
Latest News
EACR Members’ Survey 2008
If you missed the e-mail asking you to complete the 2008 EACR Members’ Survey, please visit the ‘View newsletters and publications’ page in the Members Area where there is a link to the questionnaire.
EACR-20 Registration - Members Late-Rate open until 2 June 2008
Registration is now open for EACR-20 with an excellent ‘late-rate’ for EACR Members. Late Rate payments must be made before 2 June 2008.
Keep contact details up to date to receive regular EACR news by e-mail and air-mail
Members' Items
How to apply for a Meeting Bursary to attend EACR-20
Meeting Bursary applications will be evaluated on 23 April 2008 and all applicants will be notified as soon as possible around the middle of May 2008.
Jobs and Study Opportunities
Postdoctoral position available
The package includes a competitive salary 36.000 euros/year, managerial and scientific training and a number of benefits.
IFOM-IEO Campus, Milan, Italy
For further information >Cancer Research Opportunities at IRCC (Italy) for post-docs and a junior P.I.
The Division of Molecular Oncology at the Institute for Cancer Research and Treatment (IRCC) invites applications for three post-doctoral positions, to study the function of Met and the semaphorins in cancer progression, with particular interest for identifying the implicated molecular mechanisms and developing molecular tools to target these pathways in human tumors. In addition, we welcome applications for one tenure-track position reserved to young independent investigators, with outstanding qualification in this field.
Post-Doctoral Position, The Immunotherapy & Gene Therapy Unit
The Immunotherapy & Gene Therapy Unit seeks a candidate with experience in immunology to study regulatory T cells expansion, conversion and inactivation in tumor bearers using a variety of mixed bone marrow chimeras as well as gene shut down in bone marrow donors.